News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
245,585 Results
Type
Article (5498)
Company Profile (16)
Press Release (240071)
Multimedia
Podcasts (5)
Webinars (4)
Section
Business (96291)
Career Advice (475)
Deals (15342)
Drug Delivery (10)
Drug Development (20221)
Employer Resources (33)
FDA (3927)
Job Trends (4254)
News (124073)
Policy (7983)
Tag
2027 BioCapital Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (340)
Accelerated approval (14)
ADA (11)
Adcomms (4)
Allergies (29)
Alliances (15406)
ALS (56)
Alzheimer's disease (357)
Antibody-drug conjugate (ADC) (102)
Approvals (4131)
Artificial intelligence (163)
ASCO (52)
Autoimmune disease (84)
Automation (15)
Bankruptcy (97)
Belgium (1)
Best Places to Work (3174)
BIO (21)
Biologics (4)
Biosimilars (51)
BioSpace Insights (12)
Biotechnology (20)
Bladder cancer (54)
Brain cancer (16)
Breast cancer (141)
Cancer (1382)
Cardiovascular disease (103)
Career advice (407)
Career pathing (5)
CAR-T (92)
CDC (3)
CDMO (13)
Celiac Disease (1)
Cell therapy (237)
Cervical cancer (11)
Clinical research (18337)
Collaboration (564)
Commercialization (2)
Compensation (568)
Complete response letters (18)
COVID-19 (326)
CRISPR (22)
C-suite (605)
Cystic fibrosis (33)
Data (2190)
Denatured (2)
Depression (29)
Dermatology (35)
Diabetes (135)
Diagnostics (2266)
Digital health (15)
Diversity (2)
Diversity, equity & inclusion (15)
Drug discovery (68)
Drug pricing (38)
Drug shortages (2)
Duchenne muscular dystrophy (56)
Earnings (45109)
Editorial (6)
Employer branding (7)
Employer resources (36)
Events (41646)
Executive appointments (551)
FDA (4982)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (9)
Frontotemporal dementia (14)
Funding (474)
Gene editing (36)
Generative AI (7)
Gene therapy (139)
GLP-1 (184)
Government (539)
Guidances (214)
Healthcare (5381)
Hematology (59)
HIV (17)
Huntington's disease (12)
IgA nephropathy (35)
Immunology and inflammation (56)
Immuno-oncology (23)
Indications (49)
Infectious disease (367)
Inflammatory bowel disease (42)
Inflation Reduction Act (4)
Influenza (12)
Intellectual property (44)
Interviews (56)
IPO (8006)
IRA (6)
Job creations (1152)
Job search strategy (367)
JPM (4)
Kidney cancer (17)
Labor market (17)
Layoffs (123)
Leadership (7)
Legal (2442)
Licensing (6)
Liver cancer (26)
Longevity (7)
Lung cancer (159)
Lymphoma (131)
Machine learning (12)
Management (10)
Manufacturing (264)
Marketing (4)
MASH (67)
Medical affairs (1)
Medical device (4020)
Medtech (4079)
Mergers & acquisitions (7896)
Metabolic disorders (343)
mRNA (23)
Multiple sclerosis (29)
NASH (6)
Netherlands (1)
Neurodegenerative disease (95)
Neuropsychiatric disorders (14)
Neuroscience (738)
NextGen: Class of 2026 (1736)
Non-profit (767)
Now hiring (11)
Obesity (132)
Opinion (40)
Ovarian cancer (50)
Pain (39)
Pancreatic cancer (73)
Parkinson's disease (86)
Partnered (6)
Patents (86)
Patient recruitment (173)
Patient selection (1)
Peanut (6)
People (26552)
Peptides (1)
Pharmaceutical (6)
Pharmacy benefit managers (34)
Phase 1 (5440)
Phase 2 (7892)
Phase 3 (6432)
Pipeline (4120)
Policy (41)
Postmarket research (677)
Preclinical (2109)
Press Release (66)
Prostate cancer (81)
Psychedelics (4)
Radiopharmaceuticals (145)
Rare diseases (291)
Real estate (1963)
Recruiting (9)
Regenerative medicine (1)
Regulatory (6238)
Reports (24)
Research institute (335)
Resumes & cover letters (71)
Rett syndrome (31)
RNA editing (2)
RSV (2)
Schizophrenia (64)
Series A (84)
Series B (72)
Sickle cell disease (22)
Special edition (4)
Spinal muscular atrophy (37)
Sponsored (6)
Startups (1061)
Stomach cancer (1)
Supply chain (28)
Tariffs (9)
The Weekly (3)
Vaccines (112)
Venture capital (21)
Weight loss (53)
Women's health (14)
Worklife (1)
Date
Today (26)
Last 7 days (134)
Last 30 days (595)
Last 365 days (9311)
2026 (6750)
2025 (9374)
2024 (11435)
2023 (13663)
2022 (19141)
2021 (20278)
2020 (18813)
2019 (13779)
2018 (10639)
2017 (10309)
2016 (9482)
2015 (12484)
2014 (9915)
2013 (7958)
2012 (8624)
2011 (9114)
2010 (8925)
Location
Africa (191)
Alabama (22)
Alaska (2)
Arizona (91)
Arkansas (2)
Asia (12622)
Australia (1878)
California (4912)
Canada (1479)
China (286)
Colorado (190)
Connecticut (240)
Delaware (96)
Europe (27109)
Florida (765)
Georgia (104)
Hawaii (1)
Idaho (24)
Illinois (234)
India (43)
Indiana (151)
Iowa (10)
Japan (287)
Kansas (48)
Kentucky (22)
Louisiana (12)
Maine (60)
Maryland (466)
Massachusetts (4023)
Michigan (113)
Minnesota (250)
Mississippi (1)
Missouri (46)
Montana (18)
Nebraska (12)
Nevada (61)
New Hampshire (16)
New Jersey (1807)
New Mexico (6)
New York (1108)
North Carolina (634)
North Dakota (6)
Northern California (2644)
Ohio (164)
Oklahoma (6)
Oregon (7)
Pennsylvania (833)
Puerto Rico (4)
Rhode Island (20)
South America (285)
South Carolina (20)
Southern California (1879)
Tennessee (86)
Texas (720)
United States (17483)
Utah (165)
Vermont (1)
Virginia (125)
Washington D.C. (20)
Washington State (437)
West Virginia (2)
Wisconsin (81)
Wyoming (2)
245,585 Results for "princeton biomeditech corporation pbm".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Rapalogix Health Establishes Research Laboratory at Princeton Innovation Center BioLabs to Advance Next-Generation Rapalogs
September 2, 2026
·
3 min read
Genetown
C2Sense® and Princeton BioMeditech Receive Second Award from NIH RADx® Tech High Performance Program for Digitally Connected, At-Home Diagnostic Reader and Multiplex COVID-19/Flu A&B Rapid Test
C2Sense, Inc., experts in advanced optical sensing platforms and Princeton BioMeditech Corporation, a world leader in rapid, point-of-care diagnostics, announced that they have secured a second National Institutes of Health Rapid Acceleration of Diagnostics Tech High Performance award.
April 9, 2024
·
3 min read
Press Releases
Abarca Health and LucyRx Announce Strategic Combination to Create the Only Modern PBM Built for Commercial and Government Scale
June 18, 2026
·
4 min read
Rare diseases
Rare Pediatric Disease Vouchers Reauthorized, PBM Reform Funded in Narrowly Passed Spending Bill
U.S. President Donald Trump signed a spending package into law Tuesday that reauthorizes the FDA’s previously stalled rare pediatric disease priority review voucher program, among other initiatives, while ending a three-day partial government shutdown.
February 3, 2026
·
3 min read
·
Heather McKenzie
Press Releases
Marpai Inc. Announces Unprecedented Growth with 192,000 New Estimated Member Lives Across TPA and MarpaiRx PBM Platforms; Expects to Achieve Positive Cash Flow and EBITDA Beginning August 2026
May 26, 2026
·
4 min read
C-suite
Novo drops ‘Nordisk’ moniker, turns bull toward future in corporate rebrand
Analysts tentatively welcomed Novo’s new corporate rebrand—so long as it comes with a larger change to the company’s overall business strategy.
September 14, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
AHF Commends Gov. Newsom for Signing PBM Reform Bill (SB 41, Weiner)
October 13, 2025
·
1 min read
PBMs
Deep Dive: PBM Reform
In the battle over drug prices, one sector of the healthcare industry has risen above all the players as the boogeyman: pharmacy benefit managers. In this special edition of BioPharm Executive,
BioSpace
takes a deep dive into the lens now focused on PBMs’ business practices.
September 18, 2024
·
2 min read
·
Annalee Armstrong
Pharmacy benefit managers
Trump’s Most Favored Nation Policy Sparks PBM Selloff
The Most Favored Nation directive would allow drugmakers to directly sell their products to patients at a lower cost, cutting out what President Donald Trump called “the middlemen.”
May 13, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Britannia Life Sciences Provides Corporate Update
Corporate Treasury Positioned with Cash and Liquid Equity Holdings to Seed, Incubate and Accelerate New and Existing Operations
May 21, 2026
·
4 min read
1 of 24,559
Next
